These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16988659)

  • 21. Gene therapy put on hold as third child develops cancer.
    Check E
    Nature; 2005 Feb; 433(7026):561. PubMed ID: 15703711
    [No Abstract]   [Full Text] [Related]  

  • 22. US panel advises resumption of gene trials.
    Fox JL
    Nat Biotechnol; 2002 Nov; 20(11):1068-9. PubMed ID: 12410240
    [No Abstract]   [Full Text] [Related]  

  • 23. Gene therapy. Second child in French trial is found to have leukemia.
    Marshall E
    Science; 2003 Jan; 299(5605):320. PubMed ID: 12531981
    [No Abstract]   [Full Text] [Related]  

  • 24. A novel splice-site mutation in the common gamma chain (gammac) gene IL2RG results in X-linked severe combined immunodeficiency with an atypical NK+ phenotype.
    Ginn SL; Smyth C; Wong M; Bennetts B; Rowe PB; Alexander IE
    Hum Mutat; 2004 May; 23(5):522-3. PubMed ID: 15108287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical research. Gene therapy a suspect in leukemia-like disease.
    Marshall E
    Science; 2002 Oct; 298(5591):34-5. PubMed ID: 12364755
    [No Abstract]   [Full Text] [Related]  

  • 26. Gene therapy for severe combined immune deficiency.
    Qasim W; Gaspar HB; Thrasher AJ
    Expert Rev Mol Med; 2004 Jul; 6(13):1-15. PubMed ID: 15236670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy for immune disorders: good news tempered by bad news.
    Puck JM; Malech HL
    J Allergy Clin Immunol; 2006 Apr; 117(4):865-9. PubMed ID: 16630946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Looking into the safety of AAV vectors.
    Kay MA; Nakai H
    Nature; 2003 Jul; 424(6946):251. PubMed ID: 12867952
    [No Abstract]   [Full Text] [Related]  

  • 29. Gene therapy: the moving finger.
    High KA
    Nature; 2005 Jun; 435(7042):577-9. PubMed ID: 15931206
    [No Abstract]   [Full Text] [Related]  

  • 30. LMO2 and gene therapy for severe combined immunodeficiency.
    Fischer A; Abina SH; Thrasher A; von Kalle C; Cavazzana-Calvo M
    N Engl J Med; 2004 Jun; 350(24):2526-7; author reply 2526-7. PubMed ID: 15190153
    [No Abstract]   [Full Text] [Related]  

  • 31. Gene therapy. Panel urges limits on X-SCID trials.
    Kaiser J
    Science; 2005 Mar; 307(5715):1544-5. PubMed ID: 15761128
    [No Abstract]   [Full Text] [Related]  

  • 32. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
    Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
    Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Success for gene therapy: render unto Caesar that which is Caesar's.
    Qiao J; Diaz RM; Vile RG
    Genome Biol; 2004; 5(8):237. PubMed ID: 15287968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Setback for gene therapy: Two cases of leukemia in a French trial].
    Richter J; Relander T; Fasth A; Karlsson S
    Lakartidningen; 2003 Feb; 100(7):498-500. PubMed ID: 12640983
    [No Abstract]   [Full Text] [Related]  

  • 35. US authorities uphold suspension of SCID gene therapy.
    Fox JL
    Nat Biotechnol; 2003 Mar; 21(3):217. PubMed ID: 12610555
    [No Abstract]   [Full Text] [Related]  

  • 36. Genes can come true.
    Phillips H
    New Sci; 2002 Nov; 176(2371):30-3. PubMed ID: 12731520
    [No Abstract]   [Full Text] [Related]  

  • 37. Temporary halt on gene therapy trials.
    FDA Consum; 2003; 37(2):6. PubMed ID: 12715756
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficient detection of thirty-seven new IL2RG mutations in human X-linked severe combined immunodeficiency.
    Niemela JE; Puck JM; Fischer RE; Fleisher TA; Hsu AP
    Clin Immunol; 2000 Apr; 95(1 Pt 1):33-8. PubMed ID: 10794430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy. As Gelsinger case ends, gene therapy suffers another blow.
    Couzin J; Kaiser J
    Science; 2005 Feb; 307(5712):1028. PubMed ID: 15718439
    [No Abstract]   [Full Text] [Related]  

  • 40. Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT).
    Gansbacher B;
    J Gene Med; 2003 Mar; 5(3):261-2. PubMed ID: 12666192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.